Ian F. Smith
2011
In 2011, Ian F. Smith earned a total compensation of $3.3M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $425,493 |
|---|---|
| Option Awards | $1,914,319 |
| Salary | $523,535 |
| Stock Awards | $468,738 |
| Other | $12,495 |
| Total | $3,344,580 |
Smith received $1.9M in option awards, accounting for 57% of the total pay in 2011.
Smith also received $425.5K in non-equity incentive plan, $523.5K in salary, $468.7K in stock awards and $12.5K in other compensation.
Rankings
In 2011, Ian F. Smith's compensation ranked 1,846th out of 10,747 executives tracked by ExecPay. In other words, Smith earned more than 82.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,846 out of 10,747 | 83rd |
Division Manufacturing | 673 out of 3,960 | 83rd |
Major group Chemicals And Allied Products | 144 out of 1,033 | 86th |
Industry group Drugs | 81 out of 781 | 90th |
Industry Pharmaceutical Preparations | 68 out of 571 | 88th |
Source: SEC filing on March 28, 2014.
Smith's colleagues
We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2011.